It is #FACT: Unifesp tests 'tumor freezing' technique against early breast cancer
Unifesp in Brazil is testing an innovative 'tumor freezing' technique for early-stage breast cancer treatment, but viral messaging surrounding it contains inaccuracies.
The article reports on an innovative technique being tested at the Federal University of São Paulo (Unifesp) that involves freezing tumors as a treatment for early-stage breast cancer. While the technique, known as cryoablation, is already used in countries like the USA and Japan, the viral WhatsApp message claiming a 100% effectiveness rate in initial tests is misleading. This has raised questions among readers who sought clarification from the media outlet.
The message circulating on WhatsApp has generated interest and concern, as it suggests a significant breakthrough in cancer treatment. Cryoablation involves the targeted freezing of tumors to destroy cancerous cells, potentially offering a new avenue for patients facing early breast cancer. The article emphasizes the need for a critical approach to health information shared on social media, highlighting that while exciting advancements are underway, it's crucial to verify claims before accepting them as fact.
Moreover, this testing at Unifesp could lead to further development and research in the field of oncology. However, as the article stresses, careful communication regarding the efficacy and safety of new treatments will be essential in guiding patients and shaping public perceptions. As this research progresses, it may influence future treatment protocols for breast cancer, with the hope of providing more effective options for patients in Brazil and beyond.